Search
departments › ... › admissions
… a picture of the department as is possible in a short visit. … CST Register for Menninger/BCM Psychiatry Open House 2025-2026 … accepting PGY-II transfer applications for academic year 26-27. Please check back in fall 2026 regarding the availability of transfer positions for …
healthcare › ... › meet-our-team
… needs , including preconception counseling, routine well-visits and preventative care, menopause management , …
research › ... › news
… August 2023: … August 2023: … August 2021: … August 2019: …
healthcare › ... › lions-eye-bank
… For more information on Lions Clubs International , please visit their website. …
healthcare › ... › breast-cancer-treatment-options
… at the Smith Breast Center are at the forefront of the latest technologies and treatments. They conduct research …
healthcare › clinical-trials › h-44098
… Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. … RPC-3201: A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease …
healthcare › clinical-trials › h-42481
… The purpose of this study is to compare the usual approach (no more treatment, additional … Testing Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple-Negative Breast Cancer …
about-us › ... › organ-donation-policy
… someone is added to the national transplant waiting list. Unfortunately, nearly half of all listed candidates will die waiting for a transplant. Research suggests there are … (OPOs). Baylor College of Medicine supports these efforts – firmly believing that more accountability is needed …
news › baylor-and-texas-childrens-collaborate-with-incepta-vaccine-ltd-to-develop-a-covid-19-vaccine-for-bangladesh
… Incepta Vaccine Ltd. today announced a licensing agreement for the development of a safe, effective and affordable … vaccine. Incepta Vaccine Ltd. is a vaccine manufacturing company founded in 2011 that provides high-quality vaccines … Bangladesh and across the globe. Incepta has licensed a recombinant protein COVID-19 vaccine technology developed by …